One particularly bad flare-up, known as a pulmonary exacerbation, had her coughing up blood in 2019, so she was put on the newly approved breakthrough medication. Within a month, her lung function increased by 20%, she said, and her health improved. Before she started taking Trakafta, she...
In mid-November, the White House requested that Congress approve an additional $2.5 billion for COVID therapeutics and vaccines to make sure people can afford the medications when they're no longer free. But there's little hope it will be approved — the Senatevoted that same day to endthe...
The advisory committee deferred a decision on a third booster, produced by Novavax, because the FDA hasn’t yet approved it. Here’s what to know. Who should get the COVID-19 booster? The CDC advises that everyone over 6 months old should, for the broader benefit of all. Those at ...
aTreatment options for RSV infections are still limited lnitially a polyclonal RSV antibody (RSV-IGIV,Medlmmune)was developed,it was then replaced by the newer humanized monoclonal antibody(palivizumab,Medlmmune)Palivizumab, the only FDA-approved monoclonal antibody for RSV,targets the highly conserved ...
Small molecules are medicines that target particular aspects of the immune system. They represent some of the newest treatments in the Crohn's treatment toolbox, Coates said. They have been FDA-approved forulcerative colitisand are being studied for Crohn's disease. ...
In this issue, polyoxometalate clusters, which are relatively similar to hexamolybdenum halide clusters, have been widely tested for antiviral activity in vitro, mainly against human immunodeficiency virus (HIV) and respiratory syncytial virus (RSV). Some clusters showed antiviral activity and low cell...